Udayavni Special

COVID-19 vaccine trials ongoing in India: Serum Institute

Team Udayavani, Sep 9, 2020, 7:07 PM IST

New Delhi: Serum Institute of India on Wednesday said its trials of AstraZeneca’s COVID-19 vaccine candidate in the country were ongoing and had not faced any issues.

The statement came after AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in the studies got sick.

“We can’t comment much on the UK trials,” Serum Institute India (SII) said in a statement adding “as far as Indian trials are concerned, it is continuing and we have faced no issues at all.”

Serum Institute had entered into a manufacturing partnership with AstraZeneca to produce and supply 1 billion doses of the COVID-19 vaccine being developed by Oxford University.

The Indian firm is doing the clinical trials of AstraZeneca’s vaccine candidate in India.

Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.

The pause by AstraZeneca stemmed from a standard review of the company’s vaccine trials after one person developed an unexplained illness, the firm said in a statement.

The move was intended to give researchers time to examine safety data while maintaining the integrity of the trials, the British-Swedish company said

Top News

K’taka COVID-19 update: 8655 new cases, 5644 discharges, 86 deaths on Sep 24

Rhea Chakraborty procured drugs for Sushant Singh Rajput through her brother: NCB

Drugmaker Novavax begins late-stage vaccine trial in UK

Sushant case: As NCB retrieves chat conversations, WhatsApp clarifies on end-to-end encryption

CM BSY-farmer leaders meet fails; Bandh planned on Sep 28 to continue

Vodafone wins arbitration case against India over Rs 20,000 cr tax dispute

5.4-magnitude earthquake hits Ladakh

Related Articles More

K’taka COVID-19 update: 8655 new cases, 5644 discharges, 86 deaths on Sep 24

COVID-19 tally in India crosses 58-lakh mark

COVID-19 cases in India breach 57-lakh mark, recovery rate at 81.55 per cent

K’taka COVID-19 update: 6997 new cases, 5460 discharges, 38 deaths on Sep 22

Covid-19: MLA Narayan Rao’s condition critical


Padma Shri SPB: A journey of Legendary Singer | S P Balasubrahmanyam

Young man from Mangaluru builds mini tipper

Udupi Krishna temple to be open for public from September 28 | Udayavani

‘Road Politics in Times of Pandemic’: St Aloysius Institution reacts to road renaming

Mangaluru Light House Hill Road renamed as Mulki Sunder Ram Shetty Road

Latest Additions

K’taka COVID-19 update: 8655 new cases, 5644 discharges, 86 deaths on Sep 24

Moodabidri: Valvadi gram panchayat building catches fire

Pace of CBI probe into Sushant’s death has slowed down, claims family lawyer

Indian man posts edited photo with actress Alexandra Daddario, she responds

Several youngsters and activists took to the streets to protest against climate change in Delhi

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.